Trademark: 88677074
Word
SMARTDOSE
Status Date
Monday, March 4, 2024
Filing Date
Friday, November 1, 2019
Published for Opposition
Tuesday, June 1, 2021
Abandoned Date
Monday, March 4, 2024
9 downloadable computer application software for mobile phones and handheld computers, namely, interactive patient engagement and medication adherence software for users of wearable injector drug delivery systems; downloadable computer software for facilitating communication between a computer or handheld device connected to the internet and an wearable injector drug delivery system; downloadable mobile applications for communicating with an wearable injector drug delivery system and for displaying health related information
5 Infusion pumps, sold pre-filled, for facilitating subcutaneous delivery of a wide range of liquid pharmaceutical preparations to patients; infusion pumps sold pre-filled with fluids used for the subcutaneous delivery of pharmaceutical preparations to patients; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with insulin
38 telecommunications services, namely, providing e-mail and text messages notification via the internet, featuring alerts, reminders and information related to compliance with health programs relating to wearable injector drug delivery systems
35 arranging and conducting incentive reward programs for promoting consumer compliance with prescriptions for medications delivered by wearable injector drug delivery systems; promoting data collection used in improving healthcare administration and cost management in connection with wearable injector drug delivery systems by providing an interactive web site where users can provide information about health and fitness in the nature of their health programs, personal health data and prescription and health conditions, in exchange for promotional rewards consisting of discounts and special offerings on goods and/or services provided by website sponsors
44 Providing health care information relating to wearable injector drug delivery systems by global computer networks and electronic means
42 Computer services, namely, providing an interactive web site featuring technology that allows users to communicate information from wearable injector drug delivery systems; Providing temporary use of non-downloadable computer software for communicating with wearable injector drug delivery systems and for displaying health related information; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to wearable injector drug delivery systems; Providing on-line non-downloadable software for authenticating and rewarding compliance with health programs, namely, prescriptions for medications and medical treatment regimens related to wearable injector drug delivery systems; Providing on-line non-downloadable software for users to receive notifications via e-mail, instant message, short message service (SMS), multimedia message service (MMS) or text messages relating to wearable injector drug delivery systems; Research and development and consultation related thereto in the field of wearable injector drug delivery systems
The mark consists of the stylized wording "SMARTDOSE" with "SMART" in light blue relatively thicker letters, "DOSE" in gray relatively thinner letters, and the bar of the "E" in light blue and detached from the stem.
SMART DOSE
The color(s) light blue and gray is/are claimed as a feature of the mark.
Mar 4, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 4, 2024
Abandonment - No Use Statement Filed
Jul 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2023
Sou Extension 4 Granted
Jul 27, 2023
Sou Extension 4 Filed
Jul 27, 2023
Sou Teas Extension Received
Jan 6, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2023
Sou Extension 3 Granted
Jan 4, 2023
Sou Extension 3 Filed
Jan 4, 2023
Sou Teas Extension Received
Jul 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2022
Sou Extension 2 Granted
Jul 27, 2022
Sou Extension 2 Filed
Jul 27, 2022
Sou Teas Extension Received
Jan 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 26, 2022
Sou Extension 1 Granted
Jan 26, 2022
Sou Extension 1 Filed
Jan 26, 2022
Sou Teas Extension Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 23, 2021
Approved For Pub - Principal Register
Apr 21, 2021
Examiner's Amendment Entered
Apr 21, 2021
Notification Of Examiners Amendment E-Mailed
Apr 21, 2021
Examiners Amendment E-Mailed
Apr 21, 2021
Examiners Amendment -Written
Apr 8, 2021
Teas/Email Correspondence Entered
Apr 8, 2021
Correspondence Received In Law Office
Apr 8, 2021
Teas Request For Reconsideration Received
Oct 14, 2020
Notification Of Final Refusal Emailed
Oct 14, 2020
Final Refusal E-Mailed
Oct 14, 2020
Final Refusal Written
Aug 15, 2020
Teas/Email Correspondence Entered
Aug 14, 2020
Correspondence Received In Law Office
Aug 14, 2020
Teas Response To Office Action Received
Feb 14, 2020
Notification Of Non-Final Action E-Mailed
Feb 14, 2020
Non-Final Action E-Mailed
Feb 14, 2020
Non-Final Action Written
Feb 6, 2020
Assigned To Examiner
Nov 6, 2019
New Application Office Supplied Data Entered
Nov 5, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
